Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US’ Largest Medical Cannabis Program: Cross-Sectional Study
JMIR Public Health and Surveillance · 08.09.2026 · 12 · e89716-e89716
DOI: 10.2196/89716 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JMIR Public Health and Surveillance, online erschienen am 08.09.2026. Verfasst von Sebastian Jugl und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 6018 Malachowsky Hall, Gainesville, FL, United States, …. Hauptthemen laut MEDLINE: Medical Marijuana. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This research letter compared the prevalence of qualifying conditions among patients certified to use medical cannabis in Florida to population-based prevalence estimates for the same conditions and observed marked discrepancies. These findings highlight conditions that appear to be significant reasons for patients to consider medical cannabis, providing important research priorities for future research on its effectiveness and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 6018 Malachowsky Hall, Gainesville, FL, United States, 1 352-273-6268.
ORCID-Profile: Sebastian Jugl, Nicole E Smolinski, Tansu Miriam Işılay Aydoğan, Almut G Winterstein
Zitieren
APA
Jugl, S., Smolinski, N. E., Aydoğan, T. M. I., & Winterstein, A. G. (2026). Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US’ Largest Medical Cannabis Program: Cross-Sectional Study. JMIR Public Health and Surveillance, 12, e89716-e89716. https://doi.org/10.2196/89716
Vancouver
Jugl S, Smolinski NE, Aydoğan TMI, Winterstein AG. Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US’ Largest Medical Cannabis Program: Cross-Sectional Study. JMIR Public Health and Surveillance. 2026;12:e89716-e89716. doi:10.2196/89716
BibTeX
@article{Jugl2026,
author = {Jugl, Sebastian and Smolinski, Nicole E and Aydoğan, Tansu Miriam Işılay and Winterstein, Almut G},
title = {Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US’ Largest Medical Cannabis Program: Cross-Sectional Study},
journal = {JMIR Public Health and Surveillance},
year = {2026},
volume = {12},
pages = {e89716--e89716},
doi = {10.2196/89716}
}
EUVIMED